| 101/150 | US=9 / Pediatria Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 538-90. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; LEUCEMIA LINFOBLASTICA AGUDA; EPIDEMIOLOGIA; FATORES GENETICOS; PATOGENESE; PATOBIOLOGIA; CITOGENETICA; PLOIDIA; ANORMALIDADES CROMOSSOMICAS; MARCADORES BIOQUIMICOS; FARMACOGENETICA; APRESENTACAO CLINICA; ANORMALIDADES HEMATOLOGICAS; SISTEMA NERVOSO CENTRAL; TESTICULOS; FATORES PROGNOSTICOS; TRATAMENTO |
| 102/150 | US=110 / Câncer Tobinai K, Watanabe T. Adult T-cell leukemia-lymphoma. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 2425-41. ISBN 978-0-443-06695-5. |
| 103/150 | US=9 / Pediatria Golub TR, Arceci RJ. Acute myelogenous leukemia. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 591-644. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; LEUCEMIA MIELOGENA AGUDA; FATORES PREDISPONENTES; PREDISPOSICAO HEREDITARIA; HIERARQUIA DO SISTEMA HEMATOPOETICO; LEUCEMIA MIELOGENA AGUDA. CLASSIFICACAO; LEUCEMIA MIELOGENA AGUDA. APRESENTACAO CLINICA; LEUCEMIA MIELOGENA AGUDA. TRATAMENTO; FATORES PROGNOSTICOS; MECANISMOS DE RESISTENCIA A DROGAS; QUALIDADE DE VIDA |
| 104/150 | US=6 / Transplante Stein A, Forman SJ. Allogeneic and autologous hematopoietic stem cell transplantation for acute lymphoblastic leukemia and acute myelogenous leukemia in the adult. In: Soiffer RJ. Hematopoietic stem cell transplantation. 2nd ed. New Jersey: Humana Press, 2008. p. 57-82. ISBN 978-1-934115-05-3. TRANSPLANTE AUTOLOGO DE CELULAS-TRONCO HEMATOPOIETICAS; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOIETICAS; LEUCEMIA LINFOBLASTICA AGUDA; LEUCEMIA MIELOIDE AGUDA; ADULTO |
| 105/150 | US=6 / Transplante Popat U, Giralt S. Hematopoietic cell transplantation for chronic myeloid leukemia. In: Soiffer RJ. Hematopoietic stem cell transplantation. 2nd ed. New Jersey: Humana Press, 2008. p. 83-104. ISBN 978-1-934115-05-3. TRANSPLANTE DE CELULAS HEMATOPOIETICAS; LEUCEMIA MIELOIDE CRONICA; LEUCEMIA MIELOIDE CRONICA. HISTORICO; LEUCEMIA MIELOIDE CRONICA. TRATAMENTO; TRANSPLANTE ALOGENICO; FATORES PROGNOSTICOS |
| 106/150 | US=6 / Transplante Dieu RL, Gribben JG. Transplantation in chronic lymphocytic leukemia. In: Soiffer RJ. Hematopoietic stem cell transplantation. 2nd ed. New Jersey: Humana Press, 2008. p. 137-47. ISBN 978-1-934115-05-3. TRANSPLANTE EM LEUCEMIA LINFOCITICA CRONICA; TRANSPLANTE AUTOLOGO DE CELULAS TRONCO; TRANSPLANTE DE CELULAS ESTAMINAIS ALOGENICAS MIELOABLATIVA |
| 107/150 | US=6 / Transplante Alyea EP. Donor lymphocyte infusions: clinical applications and the graft-versus-leukemia effect. In: Soiffer RJ. Hematopoietic stem cell transplantation. 2nd ed. New Jersey: Humana Press, 2008. p. 687-710. ISBN 978-1-934115-05-3. DOADORES INFUSOES DE LINFOCITOS; APLICACOES CLINICAS; EFEITO ENXERTO VERSUS LEUCEMIA; MIELOMA MULTIPLO; SINDROME MIELODISPLASICA; LEUCEMIA AGUDA; LEUCEMIA LINFOCITICA CRONICA; LINFOMA; VIRUS EPSTEIN-BARR; DISTURBIOS LINFOPROLIFERATIVAS; TRANSPLANTE NAO-ABLATIVO; DOENCA ENXERTO-VERSUS-HOSPEDEIRO |
| 108/150 | Câncer Oliveira LCM, Gonçalves ALF, Lima CS, Ferreira LFG, Alcântara TM. Cancer incidence in alcoholics cared for in a public university hospital: a report of case series. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 97-101, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.97-101.pdf CONSUMO DE ALCOOL; ALCOLISMO; INCIDENCIA; NEOPLASIAS; CANCER |
| 109/150 | US=18 / Dermatologia Burg G, Kempf W, Dummer R. Cutaneous lymphoma, leukemia, and related disorders. In: Schwartz RA. Skin cancer: recognition and management. 2nd ed. Massachusetts: Blackwell Science, 2008. p. 238-66. ISBN 978-1-4051-5961-6. LINFOMA CUTANEO; LEUCEMIA; DISTURBIOS RELACIONADOS; FUNGOIDE; PELE FROUXA GRANULOMATOSA; DOENCA DE HODGKIN; PSEUDOLINFOMAS CUTANEAS; PARAPSORIASE; LEUCEMIA NA PELE; LEUCEMIA LINFOCITICA CRONICA |
| 110/150 | US=35 / Biol/Mol Quintás-Cardama A, Cortes J, Kantarjian H. Biology of chronic and acute myeloid leukemia. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 371-83. ISBN 978-1-4160-3703-3. LEUCEMIA MIELOIDE CRONICA; LEUCEMIA MIELOIDE AGUDA; BIOLOGIA MOLECULAR |
| 111/150 | US=38 / Biol/Mol Proytcheva MA. Leukemia and lymphoma immunophenotyping and cytogenetics. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2ª ed. Boca Raton: CRC, 2008. p. 221-56. ISBN 978-0-8493-1984-6. LEUCEMIA; LINFOMA IMUNOFENOTIPAGEM; CITOGENETICA; IMUNOFENOTIPAGEM; ANTICORPOS; IMUNOHISTOQUIMICA; IMUNOFENOTIPAGEM DE LEUCEMIA; LINFOMA |
| 112/150 | US=69 / Câncer Estey E. Targeted therapy in acute myelogenous leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 21-42. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; TERAPIA-ALVO NA LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE AGUDA; ATRA E ARSENICO TRIOXIDO OZOGAMICINA; FLT-3 INIBIDORES; INIBIDORES DA FARNESIL TRANSFERASE; EPIGENETICA AGENTES DE ACAO |
| 113/150 | US=69 / Câncer Tsimberidou AM, Keating MJ. Targeted therapy in chronic lymphocytic leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 61-86. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM LEUCEMIA LINFOCITICA CRONICA; CLL; PROGNOSTICO; TERAPIA; ALVO; FASE I; FLUDARABINA; ALEMTUZUMAB; RITUXIMAB; LENALIDOMIDA; TERAPIA GENETICA |
| 114/150 | US=69 / Câncer Jabbour E, Cortes J, Kantarjian H. Targeted therapy in chronic myeloid leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 87-99. ISBN 978-1-60327-423-4. TERAPIA-ALVO NA LEUCEMIA MIELOIDE CRONICA; LEUCEMIA MIELOIDE CRONICA; INIBIDOR DA TIROSINA QUINASE; RESISTENCIA; BCR-ABL |
| 115/150 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 116/150 | US=35 / Câncer Ravandi F, Giles F. Overview of AML: approaching the treatment of AML from a biological perspective. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 3-23. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; REFRATARIO; CLORETAZINE; TROXACITABINE; CLOFARABINE; MTOR; FARNESILACAO; ANTICORPOS MONOCLONAIS; AGENTES ALQUILANTES; NUCLEOSIDEOS |
| 117/150 | US=35 / Câncer Friedman AD. Molecular foundations of AML pathogenesis and physiology: aberrant transcription factors in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 27-42. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; FATORES DE TRANSCRICAO; RUNX1; C-MYB; MLL; HOXA9; WT1; EVI-1; C/EBPALFA; PU.1; RARALFA; GATA-1 |
| 118/150 | US=35 / Câncer Paker JE. Molecular foundations of AML pathogenesis and physiology: myelodysplasia-related AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 43-70. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; MIELODISPLASIA; SINDROMES MIELODISPLASICAS; LEUCEMOGENESE; APOPTOSE; PROLIFERACAO; CICLO CELULAR |
| 119/150 | US=35 / Câncer Godley LA, Le Beau MM. Molecular foundations of AML pathogenesis and physiology: therapy-related AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 71-95. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; SINDROMES MIELODISPLASICAS; TERAPIA; AGENTE ALQUILANTE; EPIPODOFILOTOXINA; DISPLASIA; COMPLICACOES A LONGO PRAZO |
| 120/150 | US=35 / Câncer Steensma DP. Molecular foundations of AML pathogenesis and physiology: the DNA damage response, DNA repair, and AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 97-131. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; RESPOSTA DE DANO DO DNA; REPARO DE DNA; RECONHECIMENTO DOS DANOS DO DNA; REPARO POR EXCISAO DE BASE; REPARO POR EXCISAO DE NUCLEOTIDEOS; RECOMBINACAO HOMOLOGA; ANEMIA DE FANCONI; SINDROME DE BLOOM; FAMILIA RECQ HELICASES; SINDROMES HEREDITARIAS; ATAXIA-TELANGIECTASIA; SINDROME DE QUEBRA DE NIJMEGEN; SINDROME DE SECKEL; PROTEINA NIBRIN |